National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
Purpose
to identify monoclonal antibodies for the prevention of malaria in lower- and middle-income countries (LMICs)
Division
Global Health
Date
October 2024
Region Served
GLOBAL
Committed amount
$2,487,000
Grant topic
Discovery and Translational Sciences, Malaria
Duration (months)
25
Grantee location
Bethesda, Maryland, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.